Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough?

Tim J. Kruser, Michael A. Vogelbaum

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e508
JournalThe Lancet Oncology
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 2017

ASJC Scopus subject areas

  • Oncology

Cite this